HOLMES SCOTT A (Chief Financial Officer) sold 0.7% of their position (1.19K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/16/2018ACC: 0001114220-18-000094
Officer· Chief Financial Officer
Since Jul 2018
-1.19K
Net shares
Net seller
$3.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.19K
Price / share
$3.04
Trade value
$3.60K
% of position
0.7%
8/15/2018
166.55K→165.37K
Total
Net shares
−1.19K
Net value
-$3.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2018 | S · Sale | −1.19K | $3.04 | $3.60K | 0.7% | 166.55K | 165.37K |
| Total | −1.19K | -$3.60K | ||||||
Derivative Transactions0
No derivative transactions reported